Shutterstock
Oxford BioDynamics, a biotechnology company developing precision medicine tests based on the EpiSwitch 3D genomics platform and Bupa, the UK’s leading health insurer, announce a strategic agreement to give Bupa patients access to OBD’s EpiSwitch CiRT (Checkpoint inhibitor Response Test).